C3.2 Defence Against Infectious Disease
C3.2 Defence Against Infectious Disease
Overview
The immune system protects the body against pathogens — disease-causing organisms including bacteria, viruses, fungi, protists, and parasites. Defence mechanisms are organised into two main categories:
Non-specific (innate) immunity — Present from birth; responds identically to all pathogens; immediate response
Specific (adaptive) immunity — Develops after exposure; targets specific pathogens; involves memory
Both systems work together to prevent infection, destroy pathogens, and provide long-term protection.
Pathogens and Disease
What is a Pathogen?
A pathogen is an organism or agent that causes disease. Pathogens include:
Type | Examples | Diseases Caused | Key Features |
|---|---|---|---|
Bacteria | Mycobacterium tuberculosis, Vibrio cholerae, Staphylococcus aureus | TB, cholera, skin infections | Prokaryotic; can produce toxins; some intracellular |
Viruses | HIV, influenza, SARS-CoV-2, measles | AIDS, flu, COVID-19, measles | Obligate intracellular parasites; use host machinery |
Fungi | Candida albicans, Tinea species | Thrush, athlete's foot, ringworm | Eukaryotic; often opportunistic |
Protists | Plasmodium, Trypanosoma, Giardia | Malaria, sleeping sickness, giardiasis | Eukaryotic; complex life cycles |
Parasitic worms | Tapeworms, roundworms, flukes | Various parasitic diseases | Multicellular; complex life cycles |
Prions | Misfolded proteins | CJD, BSE (mad cow disease) | Not living; infectious proteins |
How Pathogens Cause Disease
Toxin production — Bacteria release exotoxins (secreted) or endotoxins (from cell wall)
Cell destruction — Viruses lyse host cells upon release; some bacteria destroy tissue
Nutrient competition — Pathogens consume host nutrients
Immune response damage — Inflammation and immune reactions can damage host tissue
Disruption of normal function — Interference with cell signalling, metabolism, etc.
Non-Specific (Innate) Defences
Non-specific defences are the first and second lines of defence. They do not distinguish between different pathogens — they respond the same way to all threats.
First Line of Defence: Physical and Chemical Barriers
These prevent pathogen entry into the body.
Physical Barriers
Barrier | Location | Mechanism |
|---|---|---|
Skin | Body surface | Continuous barrier; keratinised dead cells; difficult to penetrate; low pH (acidic secretions) |
Mucous membranes | Respiratory, digestive, urogenital tracts | Mucus traps pathogens; cilia beat to move mucus out (mucociliary escalator) |
Cilia | Respiratory tract lining | Hair-like projections; sweep mucus + trapped particles toward throat |
Earwax (cerumen) | Ear canal | Traps particles; contains antimicrobial compounds |
Hairs | Nose, ears | Filter large particles from inhaled air |
Chemical Barriers
Secretion | Location | Mechanism |
|---|---|---|
Hydrochloric acid | Stomach | pH ~2; kills most ingested pathogens; denatures proteins |
Lysozyme | Tears, saliva, nasal secretions, breast milk | Enzyme that breaks down bacterial cell walls (peptidoglycan) |
Sebum | Skin (sebaceous glands) | Oily secretion; lowers skin pH; contains antimicrobial lipids |
Sweat | Skin (sweat glands) | Contains lysozyme and dermcidin (antimicrobial peptide) |
Mucus | Respiratory, digestive tracts | Sticky; traps pathogens; contains antibodies (IgA) and lysozyme |
Gastric juice | Stomach | Acid + pepsin destroys pathogens |
Vaginal secretions | Vagina | Acidic pH (~4.5) from lactic acid bacteria; inhibits pathogen growth |
Urine | Urinary tract | Acidic; flow flushes out pathogens |
Biological Barriers
Barrier | Location | Mechanism |
|---|---|---|
Normal flora (microbiota) | Skin, gut, vagina | Compete with pathogens for nutrients and space; produce antimicrobial substances; stimulate immune system |
Second Line of Defence: Internal Non-Specific Responses
If pathogens breach the first line, these mechanisms activate to contain and destroy them.
Phagocytosis
Phagocytes are white blood cells that engulf and digest pathogens.
Types of phagocytes:
Cell Type | Location | Features |
|---|---|---|
Neutrophils | Blood; migrate to infection sites | Most abundant WBC; short-lived; first responders; contain granules with antimicrobial chemicals |
Macrophages | Tissues (develop from monocytes) | Long-lived; present antigens to lymphocytes; secrete cytokines; found in liver (Kupffer cells), lungs (alveolar macrophages), brain (microglia) |
Dendritic cells | Skin, mucous membranes, lymph nodes | Specialised antigen-presenting cells; crucial link to adaptive immunity |
Process of phagocytosis:
Detection — Phagocyte recognises pathogen via pattern recognition receptors (PRRs) binding to pathogen-associated molecular patterns (PAMPs)
Chemotaxis — Phagocyte moves toward pathogen following chemical signals
Attachment — Phagocyte binds to pathogen surface; enhanced by opsonisation (coating with antibodies or complement proteins)
Engulfment — Plasma membrane extends pseudopodia around pathogen; forms phagosome (vesicle containing pathogen)
Fusion — Phagosome fuses with lysosome → phagolysosome
Digestion — Lysosomal enzymes (proteases, lysozyme) and reactive oxygen species destroy pathogen
Discharge — Debris expelled by exocytosis; some fragments displayed on cell surface as antigens (antigen presentation)
Inflammation
Inflammation is a localised response to tissue damage or infection. Cardinal signs: redness, heat, swelling, pain (rubor, calor, tumor, dolor).
Process:
Tissue damage/infection — Damaged cells and pathogens release chemicals
Mast cell activation — Release histamine and other mediators
Vasodilation — Blood vessels widen → increased blood flow → redness and heat
Increased permeability — Gaps between endothelial cells → plasma leaks into tissues → swelling (oedema)
Chemotaxis — Chemical signals attract phagocytes to the area
Phagocyte migration — Neutrophils squeeze through vessel walls (diapedesis) and engulf pathogens
Tissue repair — Once infection controlled, healing begins
Benefits of inflammation:
Delivers immune cells to infection site
Delivers clotting factors to seal wounds
Delivers nutrients for tissue repair
Dilutes toxins
Pain discourages movement (protects injured area)
Pus: Collection of dead neutrophils, pathogens, and tissue debris
Fever
Fever is a systemic response involving elevated body temperature.
Mechanism:
Phagocytes release pyrogens (e.g., interleukin-1, interleukin-6, TNF-α)
Pyrogens act on hypothalamus
Temperature set point raised
Body activates heat-generating mechanisms
Benefits:
Inhibits growth of temperature-sensitive pathogens
Speeds up immune cell metabolism and activity
Increases rate of tissue repair
Reduces iron availability (many bacteria need iron)
Risks:
Very high fever (>40°C) can be dangerous
Febrile seizures in children
Protein denaturation above 42°C
Antimicrobial Proteins
Protein | Function |
|---|---|
Interferons (IFN) | Released by virus-infected cells; warn neighbouring cells; induce antiviral state; activate NK cells |
Complement system | ~30 plasma proteins; form membrane attack complexes (MAC) that lyse pathogens; enhance phagocytosis (opsonisation); promote inflammation |
Antimicrobial peptides (defensins) | Disrupt microbial membranes; found in mucous membranes and phagocyte granules |
Natural Killer (NK) Cells
Lymphocytes of innate immunity (not B or T cells)
Recognise and destroy virus-infected cells and cancer cells
Do not require prior sensitisation
Kill by releasing perforins (create pores) and granzymes (trigger apoptosis)
Recognise cells with abnormal or absent MHC class I molecules
Specific (Adaptive) Immunity
Specific immunity develops after exposure to a pathogen. It is characterised by:
Specificity — Targets particular antigens on specific pathogens
Memory — Faster, stronger response upon re-exposure
Diversity — Can recognise millions of different antigens
Self/non-self recognition — Distinguishes body's own cells from foreign invaders
Key Concepts
Antigens
Antigen = Antibody generator
Molecules (usually proteins or glycoproteins) that trigger an immune response
Found on pathogen surfaces, toxins, pollen, transplanted tissue, etc.
Each pathogen has multiple different antigens
Self-antigens (on body's own cells) normally do not trigger immune response
Lymphocytes
Lymphocytes are white blood cells responsible for specific immunity. They originate from stem cells in bone marrow.
Type | Maturation Site | Function |
|---|---|---|
B lymphocytes (B cells) | Bone marrow | Produce antibodies (humoral immunity) |
T lymphocytes (T cells) | Thymus | Cell-mediated immunity; regulate immune response |
Each lymphocyte has receptors for ONE specific antigen. The body produces millions of different lymphocytes, collectively able to recognise any possible antigen.
B Cells and Humoral Immunity
Humoral immunity (from Latin humor = body fluid) involves antibodies circulating in blood and lymph.
B Cell Activation
Antigen binding — B cell receptor (membrane-bound antibody) binds to specific antigen
Internalisation — B cell engulfs antigen-antibody complex
Antigen presentation — Antigen fragments displayed on B cell surface with MHC class II
Helper T cell activation — Helper T cell (CD4+) recognises antigen-MHC complex
Costimulation — Helper T cell releases cytokines (especially interleukins)
Clonal selection — B cell activated to divide rapidly
Clonal expansion — Multiple copies of the same B cell produced
Differentiation — B cells differentiate into:
Plasma cells — Antibody factories
Memory B cells — Long-lived; provide immunological memory
Plasma Cells
Highly specialised for antibody production
Abundant rough ER and Golgi apparatus
Short-lived (days to weeks)
Do not divide
Secrete ~2000 antibodies per second
All antibodies identical (specific for one antigen)
Memory B Cells
Remain in body for years or decades
Do not secrete antibodies
Can rapidly differentiate into plasma cells upon re-exposure
Basis of immunological memory
Enable faster, stronger secondary immune response
Antibodies (Immunoglobulins)
Antibodies are Y-shaped glycoproteins produced by plasma cells. They bind specifically to antigens and help neutralise or eliminate pathogens.
Antibody Structure
Component | Description |
|---|---|
Heavy chains (H) | Two identical long polypeptide chains; determine antibody class |
Light chains (L) | Two identical short polypeptide chains |
Variable regions (V) | Tips of Y arms; different for each antibody; form antigen-binding sites |
Constant regions (C) | Stem of Y; same within each antibody class; determine function |
Hinge region | Flexible area between arms and stem; allows flexibility in binding |
Disulfide bonds | Hold chains together |
Antigen-binding sites | Two per antibody; formed by variable regions of H and L chains |
Antibody Classes (Isotypes)
Class | Location | Function |
|---|---|---|
IgG | Blood, tissue fluid | Most abundant; crosses placenta; long-lasting immunity |
IgM | Blood | First antibody produced; activates complement; pentamer form |
IgA | Mucous membranes, secretions (tears, saliva, breast milk) | Mucosal immunity; dimer form |
IgE | Tissues | Allergic responses; defence against parasites; binds to mast cells |
IgD | B cell surface | B cell receptor; function unclear |
How Antibodies Work
Antibodies do not directly kill pathogens. They mark them for destruction and interfere with their function:
Mechanism | Description |
|---|---|
Neutralisation | Antibodies bind to pathogen surface proteins or toxins, blocking their ability to attach to host cells or cause damage |
Agglutination | Antibodies cross-link multiple pathogens, clumping them together; easier for phagocytes to engulf |
Precipitation | Similar to agglutination but with soluble antigens; forms insoluble complexes |
Opsonisation | Antibody coating makes pathogens more recognisable to phagocytes; Fc region binds to phagocyte receptors |
Complement activation | Antibody-antigen complexes trigger complement cascade → membrane attack complex → cell lysis |
Antibody-dependent cell-mediated cytotoxicity (ADCC) | NK cells recognise antibody-coated cells and destroy them |
T Cells and Cell-Mediated Immunity
Cell-mediated immunity involves direct action of T cells against infected cells, cancer cells, and transplanted tissue.
T Cell Receptors (TCR)
Each T cell has receptors specific for ONE antigen
Unlike antibodies, TCRs remain membrane-bound
TCRs only recognise antigens presented on MHC molecules
MHC (Major Histocompatibility Complex)
MHC molecules display antigens on cell surfaces for T cell recognition.
Class | Found On | Function |
|---|---|---|
MHC Class I | All nucleated cells | Display endogenous antigens (from inside cell, e.g., viral proteins); recognised by cytotoxic T cells |
MHC Class II | Antigen-presenting cells (macrophages, dendritic cells, B cells) | Display exogenous antigens (from engulfed pathogens); recognised by helper T cells |
Types of T Cells
Helper T Cells (CD4+ T cells)
"Conductors" of the immune response
Recognise antigens on MHC class II
Do NOT directly kill pathogens
Release cytokines that:
Activate B cells → antibody production
Activate cytotoxic T cells → cell killing
Enhance macrophage activity
Promote inflammation
Essential for both humoral and cell-mediated immunity
HIV specifically targets and destroys CD4+ helper T cells, which is why AIDS causes immunodeficiency.
Cytotoxic T Cells (CD8+ T cells)
"Killer" cells
Recognise antigens on MHC class I (infected or abnormal cells)
Directly destroy target cells by:
Perforin — Creates pores in target cell membrane
Granzymes — Enter through pores; trigger apoptosis (programmed cell death)
Target:
Virus-infected cells
Cancer cells
Transplanted cells (rejection)
Intracellular bacteria (e.g., TB)
Memory T Cells
Long-lived (years to decades)
Remain after infection cleared
Rapidly activate upon re-exposure
Provide cell-mediated immunological memory
Regulatory T Cells (Treg)
Suppress immune responses
Prevent autoimmunity
Limit inflammation
Maintain self-tolerance
T Cell Activation Process
Antigen presentation — Antigen-presenting cell (APC) displays antigen on MHC
Recognition — T cell receptor binds to antigen-MHC complex
Costimulation — Additional signals required (prevents accidental activation)
Activation — T cell becomes activated
Clonal expansion — Activated T cell divides rapidly
Differentiation — Produces effector cells (helper or cytotoxic) and memory cells
Action — Effector cells carry out immune functions
Comparing B Cells and T Cells
Feature | B Cells | T Cells |
|---|---|---|
Maturation site | Bone marrow | Thymus |
Antigen recognition | Direct binding (BCR) | MHC-presented (TCR) |
Effector cells | Plasma cells | Helper T cells, Cytotoxic T cells |
Products | Antibodies | Cytokines, Perforin, Granzymes |
Type of immunity | Humoral (antibody-mediated) | Cell-mediated |
Targets | Extracellular pathogens, toxins | Intracellular pathogens, infected cells, cancer |
Memory cells | Memory B cells | Memory T cells |
Primary vs Secondary Immune Response
Primary Response
First exposure to antigen
Lag phase of 10–17 days (time to activate naive lymphocytes)
Mainly IgM produced initially, then IgG
Lower antibody levels
Memory cells formed
Secondary Response
Subsequent exposure to same antigen
Faster response (1–2 days) due to memory cells
Much higher antibody levels (10–100× more)
Mainly IgG produced
Longer-lasting protection
Basis of vaccination
Graphical Representation
Antibody
concentration
│
│ ╭────── Secondary response
│ ╱ (faster, higher)
│ ╱
│ ╭──╮ ╱
│ ╱ ╲ ╱
│ ╱ ╲ ╱
│ ╱ ╲___╱
│╱ Primary
│ response
└─────────────────────────────────→ Time
↑ ↑
1st exposure 2nd exposure
Vaccination
Vaccination (immunisation) is the deliberate exposure to antigens to stimulate adaptive immunity without causing disease.
How Vaccines Work
Vaccine introduces antigens into body
Antigens recognised by B and T cells
Primary immune response activated
Memory cells produced
Upon real infection, secondary response provides rapid protection
Types of Vaccines
Type | Description | Examples | Advantages | Disadvantages |
|---|---|---|---|---|
Live attenuated | Weakened pathogen; can replicate but not cause disease | MMR, oral polio, yellow fever | Strong, long-lasting immunity; mimics natural infection | Risk for immunocompromised; requires cold chain |
Inactivated (killed) | Pathogen killed by heat or chemicals | Influenza (injection), hepatitis A, rabies | Safe for immunocompromised; stable | Weaker response; boosters needed |
Subunit/conjugate | Purified antigens (proteins, polysaccharides) | Hepatitis B, HPV, Hib, pertussis (acellular) | Very safe; targeted response | May need adjuvants; boosters needed |
Toxoid | Inactivated toxin | Tetanus, diphtheria | Targets toxin effects | Only protects against toxin, not bacterium |
mRNA | mRNA encoding pathogen protein; host cells produce antigen | COVID-19 (Pfizer, Moderna) | Rapid development; no live pathogen | Requires cold storage; newer technology |
Viral vector | Harmless virus delivers pathogen genes | COVID-19 (AstraZeneca, J&J), Ebola | Strong immune response | Pre-existing immunity may reduce effectiveness |
Adjuvants
Substances added to vaccines to enhance immune response
Examples: aluminium salts, oil emulsions
Prolong antigen presence; activate innate immunity
Allow lower antigen doses
Herd Immunity
When sufficient proportion of population is immune
Reduces transmission; protects unvaccinated individuals
Threshold depends on pathogen transmissibility (R₀)
Herd immunity threshold ≈ 1 − (1/R₀)
Measles (R₀ ≈ 15): ~93% vaccination needed
Polio (R₀ ≈ 6): ~83% vaccination needed
Benefits of Vaccination
Individual protection against specific diseases
Herd immunity protects vulnerable populations
Disease eradication possible (smallpox achieved; polio nearly)
Cost-effective public health intervention
Reduced antibiotic use (prevents bacterial infections)
Limitations and Challenges
Some pathogens mutate rapidly (influenza, HIV)
Some pathogens evade immune memory
Vaccine hesitancy and misinformation
Cold chain requirements
Access and distribution issues
Time to develop new vaccines
Active vs Passive Immunity
Feature | Active Immunity | Passive Immunity |
|---|---|---|
How acquired | Exposure to antigen (infection or vaccination) | Transfer of antibodies from another source |
Immune response | Body produces own antibodies and memory cells | No immune response by recipient |
Memory cells | YES — produced | NO — not produced |
Duration | Long-lasting (years to lifetime) | Temporary (weeks to months) |
Time to develop | Days to weeks | Immediate |
Examples | Natural infection, vaccination | Maternal antibodies, antivenom, immunoglobulin therapy |
Natural vs Artificial Immunity
Type | Active | Passive |
|---|---|---|
Natural | Infection and recovery | Maternal antibodies (placenta, breast milk) |
Artificial | Vaccination | Injection of antibodies (antivenom, immunoglobulin) |
Maternal Immunity
IgG crosses placenta → protects newborn for first few months
IgA in colostrum and breast milk → protects mucosal surfaces
Temporary; declines as maternal antibodies degraded
Why infant vaccinations begin at 2–4 months
Monoclonal Antibodies
Monoclonal antibodies are identical antibodies produced by clones of a single B cell. They bind to ONE specific epitope (part of an antigen).
Production (Hybridoma Technology)
Immunise mouse with target antigen
Extract B cells from mouse spleen
Fuse B cells with immortal cancer cells (myeloma cells)
Creates hybridomas — immortal antibody-producing cells
Select hybridomas producing desired antibody
Clone selected hybridoma
Culture to produce large quantities of identical antibodies
Purify antibodies
Applications of Monoclonal Antibodies
Application | Mechanism | Examples |
|---|---|---|
Pregnancy tests | Detect hCG hormone in urine | Home pregnancy test kits |
Disease diagnosis | Detect specific pathogens or markers | HIV tests, COVID-19 rapid tests, cancer markers |
Cancer treatment | Target tumour-specific antigens; deliver toxins or radiation | Trastuzumab (Herceptin) for breast cancer; Rituximab for lymphoma |
Autoimmune diseases | Block inflammatory cytokines | Infliximab (anti-TNF) for rheumatoid arthritis, Crohn's disease |
Transplant rejection | Suppress T cell activation | Basiliximab (anti-IL-2 receptor) |
Research | Identify and purify specific molecules | Laboratory techniques, cell sorting |
Neutralising infections | Target pathogen proteins | Palivizumab for RSV; COVID-19 antibody treatments |
Advantages of Monoclonal Antibodies
Highly specific — target one epitope
Consistent production — identical antibodies every batch
Can be produced in large quantities
Can be modified (humanised, conjugated to drugs/radioactive isotopes)
Limitations
Expensive to produce
Mouse antibodies may trigger immune response in humans (can be "humanised")
May have side effects
Some targets difficult to access (intracellular)
Immune System Disorders
Allergies (Hypersensitivity)
Exaggerated immune response to harmless antigens (allergens)
Type I hypersensitivity involves IgE
First exposure: sensitisation (IgE produced, binds to mast cells)
Second exposure: allergen cross-links IgE → mast cell degranulation → histamine release
Symptoms: inflammation, mucus production, bronchoconstriction
Severe: anaphylaxis (systemic response; can be fatal)
Treatment: antihistamines, corticosteroids, adrenaline (epinephrine) for anaphylaxis
Autoimmune Diseases
Immune system attacks body's own tissues
Loss of self-tolerance
Examples:
Type 1 diabetes — Destroys β cells
Rheumatoid arthritis — Attacks joint tissues
Multiple sclerosis — Destroys myelin
Lupus (SLE) — Attacks multiple organs
Graves' disease — Antibodies stimulate thyroid
Immunodeficiency
Immune system fails to function properly
Primary — Genetic (e.g., SCID — severe combined immunodeficiency)
Secondary (acquired) — Due to infection, medication, malnutrition
HIV/AIDS — Virus destroys CD4+ helper T cells
Chemotherapy — Suppresses bone marrow
Immunosuppressive drugs (for transplants)
Practical Investigations
Investigating Antibody-Antigen Reactions
Agglutination tests:
Mix blood sample with anti-A and anti-B antibodies
Observe clumping (agglutination) to determine blood type
ELISA (Enzyme-Linked Immunosorbent Assay):
Detects presence of antigens or antibodies
Uses enzyme-linked antibodies that produce colour change
Quantitative measurement possible
Investigating Effect of Antimicrobials
Disc diffusion method:
Spread bacteria on agar plate
Place discs soaked in different antimicrobials
Incubate
Measure zone of inhibition (clear area around disc)
Larger zone = more effective antimicrobial
Common Exam Questions
Typical Question Types
Describe the process of phagocytosis (5–6 marks)
Pathogen detected by phagocyte
Phagocyte engulfs pathogen
Phagosome formed
Fuses with lysosome
Enzymes digest pathogen
Debris released; antigens presented
Explain how B cells produce antibodies (6 marks)
Antigen binds to B cell receptor
B cell activated (with helper T cell)
Clonal expansion
Differentiation into plasma cells
Plasma cells secrete antibodies
Memory cells formed for future response
Compare active and passive immunity (4 marks)
Active: body produces own antibodies; passive: antibodies from external source
Active: memory cells formed; passive: no memory
Active: long-lasting; passive: temporary
Active: takes time to develop; passive: immediate
Explain how vaccination provides immunity (5 marks)
Vaccine contains antigens (dead/weakened pathogen or parts)
Primary immune response triggered
B and T cells activated
Memory cells produced
Future exposure → rapid secondary response
Describe the roles of helper T cells and cytotoxic T cells (4 marks)
Helper T: release cytokines; activate B cells and cytotoxic T cells
Cytotoxic T: recognise infected cells via MHC I; kill by perforin and granzymes
Helper T: recognise MHC II; cytotoxic T: recognise MHC I
Outline applications of monoclonal antibodies (4 marks)
Diagnosis: detecting specific antigens (pregnancy test, disease testing)
Treatment: targeting cancer cells; treating autoimmune diseases
Specific binding to single epitope
Can be produced in large quantities
Key Terminology Glossary
Term | Definition |
|---|---|
Pathogen | Disease-causing organism or agent |
Antigen | Molecule that triggers immune response |
Antibody | Y-shaped protein produced by plasma cells; binds specific antigen |
Phagocyte | Cell that engulfs and digests pathogens (e.g., neutrophil, macrophage) |
Phagocytosis | Process of engulfing particles into a vesicle |
Lymphocyte | White blood cell of specific immunity (B cell or T cell) |
Plasma cell | Differentiated B cell that secretes antibodies |
Memory cell | Long-lived lymphocyte that enables rapid secondary response |
Helper T cell | CD4+ T cell that coordinates immune responses via cytokines |
Cytotoxic T cell | CD8+ T cell that kills infected or abnormal cells |
MHC | Major histocompatibility complex; displays antigens on cell surface |
Cytokine | Signalling protein released by immune cells |
Opsonisation | Coating of pathogen with antibodies or complement to enhance phagocytosis |
Clonal selection | Activation and proliferation of lymphocytes that recognise specific antigen |
Vaccination | Deliberate exposure to antigens to produce immunity |
Herd immunity | Population-level protection when sufficient proportion is immune |
Monoclonal antibody | Identical antibodies from a single B cell clone |
Summary Comparison Tables
Non-Specific vs Specific Immunity
Feature | Non-Specific (Innate) | Specific (Adaptive) |
|---|---|---|
Present from | Birth | After exposure |
Response time | Immediate (minutes to hours) | Delayed (days to weeks) |
Specificity | General (same for all pathogens) | Specific (targets particular antigens) |
Memory | No | Yes |
Components | Barriers, phagocytes, inflammation, complement, NK cells | B cells, T cells, antibodies |
Improves with exposure | No | Yes |
Humoral vs Cell-Mediated Immunity
Feature | Humoral | Cell-Mediated |
|---|---|---|
Main cells | B cells → Plasma cells | T cells (Helper and Cytotoxic) |
Effector molecule | Antibodies | Cytokines, Perforin, Granzymes |
Targets | Extracellular pathogens, toxins | Intracellular pathogens, infected cells, cancer |
MHC involvement | MHC II (for B cell activation) | MHC I (cytotoxic) and MHC II (helper) |
Memory | Memory B cells | Memory T cells |